Exacerbations of COPD are common and ... for 7–10 days recommended in current guidelines. Chronic obstructive pulmonary disease (COPD) is a condition of chronic airflow limitation that is ...

The relationship between chronic obstructive pulmonary disease (COPD ... including diagnostic criteria and management of acute exacerbation of CB (AECB) in the elderly patient.

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

Pegtarazimod is under clinical development by ReAlta Life Sciences and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

In asthma, lower end-tidal carbon dioxide may predict acute exacerbation outcomes, although other measures may be better severity indicators.

Study identifies NMLR as a predictor of 5-year mortality in COPD patients, paving the way for personalised care and improved survival outcomes.

In a report released today, Julian Harrison from BTIG reiterated a Buy rating on Mereo Biopharma Group Plc (MREO – Research Report), with a ...

Establish ongoing home care that includes physical, emotional, and spiritual care.

Analyst Cory Jubinville, PhD from LifeSci Capital maintained a Buy rating on Mereo Biopharma Group Plc (MREO – Research Report) and keeping the ...